Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy

This study evaluated the prognostic roles of murine double minute 2 (MDM2) and p53 in pancreatic cancer patients treated with gemcitabine-based chemotherapy. A total of 137 advanced or recurrent adenocarcinoma patients who were treated with gemcitabine-based palliative chemotherapy were reviewed, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shih-Hung, Lee, Jen-Chieh, Guo, Jhe-Cyuan, Kuo, Sung-Hsin, Tien, Yu-Wen, Kuo, Ting-Chun, Cheng, Ann-Lii, Yeh, Kun-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498069/
https://www.ncbi.nlm.nih.gov/pubmed/28678832
http://dx.doi.org/10.1371/journal.pone.0180628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498069/
https://www.ncbi.nlm.nih.gov/pubmed/28678832
http://dx.doi.org/10.1371/journal.pone.0180628

Ejemplares similares